Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Gryska David W, Director. Insider active across 6 companies, notably Seagen Inc.. In total, 20 filings have been published. Split: 2 buys · 1 sell. Total volume traded: €986k. Activity tracked since 14 May 2021. The latest transaction was disclosed on 5 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gryska David W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
GRYSKA DAVID W is Administrateur. He appears in 19 filings in total, and in the sampled recent filings between 2016-01-08 and 2026-06-15, the reported amounts are EUR 35,875 in buys and EUR 11,427,886 in sells, with the transaction nature mainly shown as Attribution. His listed companies are Seagen Inc., Mind Medicine (MindMed) Inc., Aerie Pharmaceuticals INC, Definium Therapeutics, Inc., Forte Biosciences, Inc., and INCYTE CORP.